LATEST ALERTS

Canada Cannabis fees rise in line with inflation…
Kentucky - United States Bill to ban delta-8 sales to under-21s land on governor’s desk…
Oklahoma - United States House approves extension to Medical Marijuana Authority’s powers…
Spain Podemos and allies call for hemp regulation…
Belgium Positive notifications list updated…
Bulgaria Industrial cannabis THC limit could be increased…
Germany Public hearing held over decriminalising cannabis…
Afghanistan Decree issued to ban hemp cultivation…
United States Bills on hemp and CBD regulatory framework reintroduced in the House…
Maryland - United States Bill updating definition of hemp and hemp product passes Senate…
Kentucky - United States Medical cannabis bill passes Senate and head to House…
Luxembourg Council of State issues opinion over cannabis legislation…

View all

News analysis

CBD can be light at the tunnel’s end for US cannabis and pharma firms

Written by Freddie Dawson || 18th March 2019 || News analysis | Companies | Geographies: North America United States

A series of year-end results from cannabis-related companies in the US demonstrates the importance of CBD to the bottom line, with volatility in much of the rest of the cannabis and pharmaceutical sectors ...

Are you already a subscriber? login here

Enjoy free subscription access

Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.

I WANT A FREE TRIAL NOW